Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a glucagon-like peptide-1 receptor agonist that helps reduce appetite and body weight through multiple metabolic pathways. Clinical trials show meaningful weight loss can begin at starting doses, with continued improvement as doses increase gradually over time. Understanding how dosage relates to your individual response is key to safe, effective treatment.
How Semaglutide Dosage Works for Weight Loss
Semaglutide weight loss therapy uses a gradual titration schedule rather than starting at full therapeutic doses. Most treatment protocols begin at 0.25 mg once weekly, allowing your body to adapt to the medication while minimizing side effects. Over 4–12 weeks, doses increase incrementally—typically to 0.5 mg, then 1.0 mg, and potentially higher—until reaching an effective maintenance level for your individual metabolism.
The relationship between semaglutide dosage and weight loss is not perfectly linear; some patients experience significant weight reduction at lower doses, while others require higher amounts to achieve their goals. Research from the STEP trials demonstrated that participants on higher doses (2.4 mg weekly) lost more weight than those on lower doses, but even 0.5 mg and 1.0 mg doses produced clinically meaningful results. Your optimal dose depends on how your body's GLP-1 receptors respond, your tolerance to side effects, and your weight loss objectives.
Typical Semaglutide Starting Doses and Escalation Schedules
Standard semaglutide dosing for weight loss typically follows this pattern: Week 1–4 at 0.25 mg weekly, Week 5–8 at 0.5 mg weekly, Week 9–12 at 1.0 mg weekly, and Week 13+ at 1.7 mg to 2.4 mg weekly depending on response and tolerance. This four-week interval between dose increases gives your body sufficient time to adjust and allows you to monitor changes in appetite, energy, and side effects. Some patients remain at 1.0 mg if they achieve their weight loss goals and feel stable, while others advance to higher doses for enhanced results.
The starting dose of 0.25 mg is deliberately low to reduce nausea and gastrointestinal discomfort during the first few weeks. Even at this minimal dose, many people report noticeable appetite suppression within days. If you experience intolerable side effects, your dose escalation can be extended or paused, allowing more time at each level before advancing.
Weight Loss Results Across Different Semaglutide Dose Levels
Clinical data from the STEP trials (Semaglutide Treatment Effect in People with obesity) revealed an average weight loss of 5–10% of body weight at 1.0 mg weekly, and 14–17% at the 2.4 mg dose over 68 weeks. However, individual outcomes vary substantially based on genetics, lifestyle, metabolism, and adherence. Some patients lose 15–20% of body weight, while others lose less; factors like diet quality, physical activity, sleep, and stress all influence results alongside medication dosage.
The dose-response relationship shows that most weight loss occurs within the first 12–20 weeks of treatment, with the rate of loss typically slowing after six months as your body reaches a new equilibrium. Continuing your medication at an effective dose helps maintain weight loss; discontinuing semaglutide often results in weight regain over months. This is why long-term, consistent therapy at your personal optimal dose is more important than chasing the highest possible dose.
Personalized Dosing and PlexusDx Precision Peptide Testing
Your genetic makeup significantly influences how your body responds to semaglutide at any given dose. PlexusDx Precision Peptide Genetic Test identifies variants in key genes—including GLP1R rs6923761 and GIPR rs1800437—that predict your sensitivity to GLP-1 pathway activation. This test analyzes 14 metabolic pathways and 150+ genetic insights to reveal whether you are likely a fast responder, moderate responder, or may need higher doses to achieve results.
By mapping your peptide genetics before or during early treatment, PlexusDx helps you and your provider make informed decisions about dose escalation timing and target maintenance levels. The Precision Peptide Genetic Test is available as a $99 add-on after your first month of compounded semaglutide treatment, allowing you to personalize your therapy based on your biology rather than a generic protocol. This approach reduces trial-and-error adjustments and helps you reach your effective dose more efficiently.
Cost-Effective Access to Compounded Semaglutide at PlexusDx
PlexusDx supplies compounded semaglutide injections from licensed 503A compounding pharmacies starting at $149 per month, with a flat-rate pricing model that means your dose may need to go up but your price won't. This transparent, predictable cost structure removes the financial uncertainty of flat per-compound pricing found at many other providers. Treatment is available in all 50 states without insurance or membership fees, and HSA and FSA funds are accepted to reduce your out-of-pocket burden.
When you're ready to optimize your treatment with genetic insights, the Precision Peptide Genetic Test adds $99 to your plan and delivers actionable information about your individual response pathways. PlexusDx combines affordability, scientific personalization, and pharmacy-grade quality to make semaglutide weight loss accessible and tailored to your unique biology.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the minimum semaglutide dosage needed to start losing weight?
Weight loss can begin at the starting dose of 0.25 mg weekly, though most people experience more noticeable appetite suppression and metabolic changes within 2–4 weeks as doses increase to 0.5 mg and higher. Individual response varies; some patients see results immediately, while others need to reach 1.0 mg or higher for significant weight loss. PlexusDx works with you to find your effective dose through gradual, monitored titration.
How long does it take to reach therapeutic semaglutide dosage?
Reaching a therapeutic maintenance dose typically takes 12–16 weeks using standard four-week intervals between dose increases (0.25 mg → 0.5 mg → 1.0 mg → 1.7–2.4 mg). If you experience side effects, your provider can extend the timeline or pause at any level. Most weight loss occurs during the first 12–20 weeks after starting, so patience during titration is important for safety and efficacy.
Can I stay on a lower semaglutide dose if it's working well?
Yes, absolutely. If you achieve your weight loss goals and feel stable at 0.5 mg, 1.0 mg, or another dose, there is no requirement to increase further. Your effective dose is the one that balances weight loss results, side effect tolerance, and your personal health objectives. PlexusDx supports maintenance at any effective dose level without additional cost increases.
What happens if semaglutide stops working at my current dose?
Some people develop tolerance over months or years, noticing reduced appetite suppression or slower weight loss at a stable dose. Your provider may recommend a temporary dose pause (2–4 weeks) to reset sensitivity, a dose increase if you haven't reached higher levels, or a switch to a dual-compound therapy like GLP-Squared (semaglutide plus tirzepatide). PlexusDx offers multiple pathways to re-engage your weight loss momentum.
How does the PlexusDx Precision Peptide Genetic Test improve my semaglutide dosing?
The test identifies genetic variants in GLP1R, GIPR, FTO, MC4R, and 10+ other metabolic genes that predict your dose response and sensitivity profile. Knowing whether you carry fast-responder or slow-responder variants helps your provider anticipate whether you'll need higher doses, experience stronger side effects, or reach therapeutic levels faster. This personalization reduces guesswork and helps you achieve optimal results more efficiently.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
The Ozempic Dilemma: Weight Loss After Gallbladder Removal
How Much Weight Does the Average Person Lose on Wegovy?